Supply Chain Council of European Union |

TherapeuticsMD rallies; to meet Q3 revenue consensus (NASDAQ:TXMD)

TherapeuticsMD (NASDAQ:TXMD) +6.1% PMbelieves that the company is on track to meet or exceed Q3 total net revenue consensus of $15.1M.

For the ANNOVERA product, orders to wholesalers, retail pharmacies and online distributors across Q3 have increased that are greater than the patient demand numbers being reported by industry prescription tracking databases.

Related posts

BUSINESS ROUNDUP | Business – Huntington Herald Dispatch


Foodshare Continues Drive-Thru Food Distribution at Rentschler Field Through August – NBC Connecticut


H-E-B announces plans to expand distribution center in Temple


Leave a Comment